HRYZ-T102
/ HRYZ BIOTECH
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2024
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: HRYZ Biotech Co.
Metastases • New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1